↓ Skip to main content

Dove Medical Press

An optimized probucol microencapsulated formulation integrating a secondary bile acid (deoxycholic acid) as a permeation enhancer

Overview of attention for article published in Drug Design, Development and Therapy, September 2014
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (53rd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

patent
1 patent

Citations

dimensions_citation
50 Dimensions

Readers on

mendeley
10 Mendeley
Title
An optimized probucol microencapsulated formulation integrating a secondary bile acid (deoxycholic acid) as a permeation enhancer
Published in
Drug Design, Development and Therapy, September 2014
DOI 10.2147/dddt.s68247
Pubmed ID
Authors

Armin Mooranian, Rebecca Negrulj, Nigel Chen-Tan, Gerald F Watts, Frank Arfuso, Hani Al-Salami

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 10 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 10 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 3 30%
Student > Doctoral Student 2 20%
Student > Ph. D. Student 2 20%
Other 1 10%
Student > Postgraduate 1 10%
Other 0 0%
Unknown 1 10%
Readers by discipline Count As %
Chemistry 3 30%
Pharmacology, Toxicology and Pharmaceutical Science 2 20%
Medicine and Dentistry 2 20%
Biochemistry, Genetics and Molecular Biology 1 10%
Nursing and Health Professions 1 10%
Other 0 0%
Unknown 1 10%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 May 2022.
All research outputs
#8,626,132
of 25,604,262 outputs
Outputs from Drug Design, Development and Therapy
#650
of 2,271 outputs
Outputs of similar age
#82,413
of 249,084 outputs
Outputs of similar age from Drug Design, Development and Therapy
#19
of 49 outputs
Altmetric has tracked 25,604,262 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,271 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 249,084 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.
We're also able to compare this research output to 49 others from the same source and published within six weeks on either side of this one. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.